Barbara Klencke

Barbara Klencke, listed as senior executive, has filed trades across 3 companies (mainly through SEC (Form 4)), most often in TScan Therapeutics, Inc., Xencor Inc and Sierra Oncology, Inc. The record holds 7 filings, for trades running from 1 July 2022 to 16 June 2026.

On the market, this insider has only ever bought: 3 purchases, €73k in total. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 3 share grants.

Half of the purchases are above €24k and half below. Across 3 purchases, this insider has always bought alone, with no colleague buying within 30 days.

The record was last updated on 8 July 2026 with a share grant in Xencor Inc. The most recent open-market purchase was published on 24 September 2024, 754 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.